Advanced Search

ICD-10-PCS code List for Serum, Toxoid and Vaccine

ICD-10-PCS code List for Serum, Toxoid and Vaccine is medical classification list by Centers for Medicare and Medicaid Services (CMS).

PCS Tables

PCS CODE

Description

Introduction of High-dose Interleukin-2 into Central Vein, Open Approach

Introduction of Low-dose Interleukin-2 into Central Vein, Open Approach

Introduction of Other Antineoplastic into Central Vein, Open Approach

Introduction of Antineoplastic, Monoclonal Antibody, into Central Vein, Open Approach

Introduction of Clofarabine into Central Vein, Open Approach

Introduction of Recombinant Human-activated Protein C into Central Vein, Open

Introduction of Other Thrombolytic into Central Vein, Open Approach

Introduction of Oxazolidinones into Central Vein, Open Approach

Introduction of Other Anti-infective into Central Vein, Open Approach

Introduction of Anti-inflammatory into Central Vein, Open Approach

Introduction of Serum, Toxoid and Vaccine into Central Vein, Open Approach

Introduction of Nutritional Substance into Central Vein, Open Approach

Introduction of Electrolytic and Water Balance Substance into Central Vein, Open Approach

Introduction of Intracirculatory Anesthetic into Central Vein, Open Approach

Introduction of Other Therapeutic Substance into Central Vein, Open Approach

Introduction of Blood Brain Barrier Disruption Substance into Central Vein, Open Approach

Introduction of Radioactive Substance into Central Vein, Open Approach

Introduction of Other Diagnostic Substance into Central Vein, Open Approach

Introduction of Analgesics, Hypnotics, Sedatives into Central Vein, Open Approach

Introduction of Platelet Inhibitor into Central Vein, Open Approach

Introduction of Antiarrhythmic into Central Vein, Open Approach

Introduction of Destructive Agent into Central Vein, Open Approach

Introduction of Insulin into Central Vein, Open Approach

Introduction of Human B-type Natriuretic Peptide into Central Vein, Open Approach

Introduction of Other Hormone into Central Vein, Open Approach

Introduction of Immunostimulator into Central Vein, Open

Introduction of Immunosuppressive into Central Vein, Open

Introduction of Vasopressor into Central Vein, Open Approach

Introduction of High-dose Interleukin-2 into Central Vein, Percutaneous Approach

Introduction of Low-dose Interleukin-2 into Central Vein, Percutaneous Approach

Introduction of Other Antineoplastic into Central Vein, Percutaneous Approach

Introduction of Antineoplastic, Monoclonal Antibody, into Central Vein, Percutaneous Approach

Introduction of Clofarabine into Central Vein, Percutaneous Approach

Introduction of Recombinant Human-activated Protein C into Central Vein, Percutaneous

Introduction of Other Thrombolytic into Central Vein, Percutaneous Approach

Introduction of Oxazolidinones into Central Vein, Percutaneous Approach

Introduction of Other Anti-infective into Central Vein, Percutaneous Approach

Introduction of Anti-inflammatory into Central Vein, Percutaneous Approach

Introduction of Serum, Toxoid and Vaccine into Central Vein, Percutaneous Approach

Introduction of Nutritional Substance into Central Vein, Percutaneous Approach

Introduction of Electrolytic and Water Balance Substance into Central Vein, Percutaneous Approach

Introduction of Embryonic Stem Cells into Central Vein, Percutaneous Approach

Introduction of Intracirculatory Anesthetic into Central Vein, Percutaneous Approach

Introduction of Other Therapeutic Substance into Central Vein, Percutaneous Approach

Introduction of Blood Brain Barrier Disruption Substance into Central Vein, Percutaneous Approach

Introduction of Glucarpidase into Central Vein, Percutaneous Approach

Introduction of Other Therapeutic Monoclonal Antibody into Central Vein, Percutaneous Approach

Introduction of Radioactive Substance into Central Vein, Percutaneous Approach

Introduction of Other Diagnostic Substance into Central Vein, Percutaneous Approach

Introduction of Analgesics, Hypnotics, Sedatives into Central Vein, Percutaneous Approach

Introduction of Platelet Inhibitor into Central Vein, Percutaneous Approach

Introduction of Antiarrhythmic into Central Vein, Percutaneous Approach

Introduction of Destructive Agent into Central Vein, Percutaneous Approach

Introduction of Insulin into Central Vein, Percutaneous Approach

Introduction of Human B-type Natriuretic Peptide into Central Vein, Percutaneous Approach

Introduction of Other Hormone into Central Vein, Percutaneous Approach

Introduction of Immunostimulator into Central Vein, Percutaneous

Introduction of Immunosuppressive into Central Vein, Percutaneous

Introduction of Vasopressor into Central Vein, Percutaneous Approach